PROVIDENCE, RI–(BUSINESS WIRE)–EpiVax, Inc, a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), …

article continues at unknown brought to you by diabetes.medtrials.info and medtrials.info